Byetta Bydureon Injuries and Lawsuit
Have you or a loved one been injured as a result of taking Byetta or Bydureon injections? If this is the case, you really should see a personal injury attorney. You or your loved one may have compensation coming to you for your Byetta or Bydureon injury.
What is Byetta or Bydureon?
Byetta and Bydureon are brand names under which the drug exenatide are sold. Exenatide is what is known as a glucagon-like peptide-1 agonist (GLP-1 agonist). These drugs mimic the effects of your body’s natural GLP-1, which is a hormone that reacts to high blood sugar by increasing insulin production.
Exenatide is a synthetic hormone that is derived from the saliva of the Gila monster. The Gila monster is a poisonous lizard that inhabits the southwestern United States.
Byetta and Bydureon are manufactured by Amylin Pharmaceuticals, which is headquartered in San Diego, California. However, Bristol-Myers Squibb bought Amylin in 2012 for $5.3 billion. In 2011, Byetta generated sales of $517.7 million, or 83% of Amylin’s $621.6 million net sales. Experts in the drug industry expect sales of Bydureon to be over $1 billion.
In its Byetta form, exenatide was approved by the U.S. Food and Drug Administration (FDA) in 2005 for the treatment of type 2 diabetes. Byetta is administered twice a day as a subcutaneous injection (under the skin) in the arm, thigh or abdomen. It is to be administered any time within 60 minutes before the first and last meal of the day.
In its Bydureon form, exenatide was approved by the FDA in January 2012. Bydureon is a longer lasting version of Byetta. It is given as a once a week injection.
Doctors usually prescribe Bydureon or Byetta to people who have type 2 diabetes and are overweight. Even though exenatide is not marketed as a weight-loss product, the drug seems to help people lose weight. People who only received Byetta lost an average of 6 pounds in a 24 week period.
The way in which Byetta and Bydureon work is by helping to increase insulin production in order to regulate blood sugar levels. In people who do not have type 2 diabetes, eating results in a rise in blood sugar. This, in turn, stimulates an insulin response from the pancreas. A person with type 2 diabetes does not produce enough insulin to react to the increase in blood sugar.
Exenatide was once declared to be an incredible advancement in the treatment of diabetes. However, the drug has now been linked to some serious side effects, such as pancreatic cancer, pancreatitis and thyroid cancer.
There are other side effects that have been associated with exenatide. The FDA made Amylin add the risk of kidney damage and failure to the warning label of Byetta. Exenatide was also linked to cardiovascular problems, such as heart attack. As a result, the release of Bydureon was delayed for several years. Then, in 2012, Bydureon was approved with the condition that Amylin had to conduct postmarket studies.
Again, if you or a loved one has been injured as a result of taking Byetta or Bydureon, you really should see a personal injury attorney.